Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitis.

Cook N, Geier A, Schmid A, Hirschfield G, Kautz A, Schattenberg JM, Balp MM.

JHEP Rep. 2020 Feb 1;2(2):100081. doi: 10.1016/j.jhepr.2020.100081. eCollection 2020 Apr.

2.

Self-testing for liver disease - response to an online liver test questionnaire.

Kautz A, Dorner R, Antoni C, Ebert M, Teufel A.

Scand J Gastroenterol. 2020 Jan;55(1):67-73. doi: 10.1080/00365521.2019.1699600. Epub 2019 Dec 10.

PMID:
31822163
3.

Elimination of hepatitis C virus in Germany: modelling the cost-effectiveness of HCV screening strategies.

Krauth C, Rossol S, Ortsäter G, Kautz A, Krüger K, Herder B, Stahmeyer JT.

BMC Infect Dis. 2019 Dec 2;19(1):1019. doi: 10.1186/s12879-019-4524-z.

4.

Systemic sclerostin antibody treatment increases osseointegration and biomechanical competence of zoledronic-acid-coated dental implants in a rat osteoporosis model.

Korn P, Kramer I, Schlottig F, Tödtman N, Eckelt U, Bürki A, Ferguson SJ, Kautz A, Schnabelrauch M, Range U, Kneissel M, Stadlinger B.

Eur Cell Mater. 2019 May 17;37:333-346. doi: 10.22203/eCM.v037a20.

5.

The Patient Perspectives on Future Therapeutic Options in NASH and Patient Needs.

Cook N, Geier A, Schmid A, Hirschfield G, Kautz A, Schattenberg JM, Balp MM.

Front Med (Lausanne). 2019 Apr 3;6:61. doi: 10.3389/fmed.2019.00061. eCollection 2019.

6.

Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.

Papatheodoridis GV, Hatzakis A, Cholongitas E, Baptista-Leite R, Baskozos I, Chhatwal J, Colombo M, Cortez-Pinto H, Craxi A, Goldberg D, Gore C, Kautz A, Lazarus JV, Mendão L, Peck-Radosavljevic M, Razavi H, Schatz E, Tözün N, van Damme P, Wedemeyer H, Yazdanpanah Y, Zuure F, Manns MP.

J Viral Hepat. 2018 Mar;25 Suppl 1:6-17. doi: 10.1111/jvh.12875. Review.

PMID:
29508946
7.

CO-releasing molecule (CORM) conjugate systems.

Kautz AC, Kunz PC, Janiak C.

Dalton Trans. 2016 Nov 15;45(45):18045-18063.

PMID:
27808304
8.

Recommandations pour la prise en charge de l'infection par le virus de l'hépatite C chez les usagers de drogues par injection.

Grebely J, Robaeys G, Bruggmann P, Aghemo A, Backmund M, Bruneau J, Byrne J, Dalgard O, Feld JJ, Hellard M, Hickman M, Kautz A, Litwin A, Lloyd AR, Mauss S, Prins M, Swan T, Schaefer M, Taylor LE, Dore GJ; l’International Network on Hepatitis among Substance Users (Réseau international sur l’hépatite chez les consommateurs de drogues).

Int J Drug Policy. 2015 Nov 28. pii: S0955-3959(15)00351-5. doi: 10.1016/j.drugpo.2015.11.009. [Epub ahead of print] No abstract available.

PMID:
26847504
9.

Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference.

Papatheodoridis G, Thomas HC, Golna C, Bernardi M, Carballo M, Cornberg M, Dalekos G, Degertekin B, Dourakis S, Flisiak R, Goldberg D, Gore C, Goulis I, Hadziyannis S, Kalamitsis G, Kanavos P, Kautz A, Koskinas I, Leite BR, Malliori M, Manolakopoulos S, Matičič M, Papaevangelou V, Pirona A, Prati D, Raptopoulou-Gigi M, Reic T, Robaeys G, Schatz E, Souliotis K, Tountas Y, Wiktor S, Wilson D, Yfantopoulos J, Hatzakis A.

J Viral Hepat. 2016 Feb;23 Suppl 1:1-12. doi: 10.1111/jvh.12493.

PMID:
26809941
10.

Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden.

Grebely J, Robaeys G, Bruggmann P, Aghemo A, Backmund M, Bruneau J, Byrne J, Dalgard O, Feld JJ, Hellard M, Hickman M, Kautz A, Litwin A, Lloyd AR, Mauss S, Prins M, Swan T, Schaefer M, Taylor LE, Dore GJ; im Namen vom International Network on Hepatitis care in Substance Users.

Int J Drug Policy. 2015 Nov 28. pii: S0955-3959(15)00352-7. doi: 10.1016/j.drugpo.2015.11.010. [Epub ahead of print] German. No abstract available.

PMID:
26749563
11.

Recommendations for the management of hepatitis C virus infection among people who inject drugs.

Grebely J, Robaeys G, Bruggmann P, Aghemo A, Backmund M, Bruneau J, Byrne J, Dalgard O, Feld JJ, Hellard M, Hickman M, Kautz A, Litwin A, Lloyd AR, Mauss S, Prins M, Swan T, Schaefer M, Taylor LE, Dore GJ; International Network for Hepatitis in Substance Users.

Int J Drug Policy. 2015 Oct;26(10):1028-38. doi: 10.1016/j.drugpo.2015.07.005. Epub 2015 Jul 17.

12.

Improved hepatitis C screening and treatment in people who inject drugs should be a priority in Europe.

Kautz A, Chavdarova L, Walker M.

BMC Infect Dis. 2014;14 Suppl 6:S3. doi: 10.1186/1471-2334-14-S6-S3. Epub 2014 Sep 19. No abstract available.

13.

Cholinergic nerve fibers in bone defects of a rat osteoporosis model and their regulation by implantation of bone substitution materials.

Lips KS, Kauschke V, Hartmann S, Thormann U, Ray S, Schumacher M, Gelinsky M, Heinemann S, Hanke T, Kautz AR, Schnabelrauch M, Szalay G, Heiss C, Schnettler R, Alt V, Kilian O.

J Musculoskelet Neuronal Interact. 2014 Jun;14(2):173-88.

14.

Strategies to manage hepatitis C virus (HCV) disease burden.

Wedemeyer H, Duberg AS, Buti M, Rosenberg WM, Frankova S, Esmat G, Örmeci N, Van Vlierberghe H, Gschwantler M, Akarca U, Aleman S, Balık I, Berg T, Bihl F, Bilodeau M, Blasco AJ, Brandão Mello CE, Bruggmann P, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cornberg M, Cramp ME, Dore GJ, Doss W, El-Sayed MH, Ergör G, Estes C, Falconer K, Félix J, Ferraz ML, Ferreira PR, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Guimarães Pessôa M, Hézode C, Hindman SJ, Hofer H, Husa P, Idilman R, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marinho RT, Marotta P, Mauss S, Mendes Correa MC, Moreno C, Müllhaupt B, Myers RP, Nemecek V, Øvrehus AL, Parkes J, Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, Roudot-Thoraval F, Ryder SD, Sarmento-Castro R, Sarrazin C, Semela D, Sherman M, Shiha GE, Sperl J, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, Van Damme P, van Thiel I, Vandijck D, Vogel W, Waked I, Weis N, Wiegand J, Yosry A, Zekry A, Negro F, Sievert W, Gower E.

J Viral Hepat. 2014 May;21 Suppl 1:60-89. doi: 10.1111/jvh.12249.

PMID:
24713006
15.

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm.

Razavi H, Waked I, Sarrazin C, Myers RP, Idilman R, Calinas F, Vogel W, Mendes Correa MC, Hézode C, Lázaro P, Akarca U, Aleman S, Balık I, Berg T, Bihl F, Bilodeau M, Blasco AJ, Brandão Mello CE, Bruggmann P, Buti M, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cramp ME, Dore GJ, Doss W, Duberg AS, El-Sayed MH, Ergör G, Esmat G, Falconer K, Félix J, Ferraz ML, Ferreira PR, Frankova S, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Gower E, Gschwantler M, Guimarães Pessôa M, Hindman SJ, Hofer H, Husa P, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Marinho RT, Marotta P, Mauss S, Moreno C, Murphy K, Negro F, Nemecek V, Örmeci N, Øvrehus AL, Parkes J, Pasini K, Peltekian KM, Ramji A, Reis N, Roberts SK, Rosenberg WM, Roudot-Thoraval F, Ryder SD, Sarmento-Castro R, Semela D, Sherman M, Shiha GE, Sievert W, Sperl J, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, Van Damme P, van Thiel I, Van Vlierberghe H, Vandijck D, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Cornberg M, Müllhaupt B, Estes C.

J Viral Hepat. 2014 May;21 Suppl 1:34-59. doi: 10.1111/jvh.12248.

PMID:
24713005
16.

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

Bruggmann P, Berg T, Øvrehus AL, Moreno C, Brandão Mello CE, Roudot-Thoraval F, Marinho RT, Sherman M, Ryder SD, Sperl J, Akarca U, Balık I, Bihl F, Bilodeau M, Blasco AJ, Buti M, Calinas F, Calleja JL, Cheinquer H, Christensen PB, Clausen M, Coelho HS, Cornberg M, Cramp ME, Dore GJ, Doss W, Duberg AS, El-Sayed MH, Ergör G, Esmat G, Estes C, Falconer K, Félix J, Ferraz ML, Ferreira PR, Frankova S, García-Samaniego J, Gerstoft J, Giria JA, Gonçales FL Jr, Gower E, Gschwantler M, Guimarães Pessôa M, Hézode C, Hofer H, Husa P, Idilman R, Kåberg M, Kaita KD, Kautz A, Kaymakoglu S, Krajden M, Krarup H, Laleman W, Lavanchy D, Lázaro P, Marotta P, Mauss S, Mendes Correa MC, Müllhaupt B, Myers RP, Negro F, Nemecek V, Örmeci N, Parkes J, Peltekian KM, Ramji A, Razavi H, Reis N, Roberts SK, Rosenberg WM, Sarmento-Castro R, Sarrazin C, Semela D, Shiha GE, Sievert W, Stärkel P, Stauber RE, Thompson AJ, Urbanek P, van Thiel I, Van Vlierberghe H, Vandijck D, Vogel W, Waked I, Wedemeyer H, Weis N, Wiegand J, Yosry A, Zekry A, Van Damme P, Aleman S, Hindman SJ.

J Viral Hepat. 2014 May;21 Suppl 1:5-33. doi: 10.1111/jvh.12247. Review.

PMID:
24713004
17.

Podoplanin immunopositive lymphatic vessels at the implant interface in a rat model of osteoporotic fractures.

Lips KS, Kauschke V, Hartmann S, Thormann U, Ray S, Kampschulte M, Langheinrich A, Schumacher M, Gelinsky M, Heinemann S, Hanke T, Kautz AR, Schnabelrauch M, Schnettler R, Heiss C, Alt V, Kilian O.

PLoS One. 2013 Oct 9;8(10):e77259. doi: 10.1371/journal.pone.0077259. eCollection 2013.

18.

Recommendations for the management of hepatitis C virus infection among people who inject drugs.

Robaeys G, Grebely J, Mauss S, Bruggmann P, Moussalli J, De Gottardi A, Swan T, Arain A, Kautz A, Stöver H, Wedemeyer H, Schaefer M, Taylor L, Backmund M, Dalgard O, Prins M, Dore GJ; International Network on Hepatitis in Substance Users.

Clin Infect Dis. 2013 Aug;57 Suppl 2:S129-37. doi: 10.1093/cid/cit302.

PMID:
23884061
19.

The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference.

Hatzakis A, Van Damme P, Alcorn K, Gore C, Benazzouz M, Berkane S, Buti M, Carballo M, Cortes Martins H, Deuffic-Burban S, Dominguez A, Donoghoe M, Elzouki AN, Ben-Alaya Bouafif N, Esmat G, Esteban R, Fabri M, Fenton K, Goldberg D, Goulis I, Hadjichristodoulou C, Hatzigeorgiou T, Hamouda O, Hasurdjiev S, Hughes S, Kautz A, Malik M, Manolakopoulos S, Matičič M, Papatheodoridis G, Peck R, Peterle A, Potamitis G, Prati D, Roudot-Thoraval F, Reic T, Sharara A, Shennak M, Shiha G, Shouval D, Sočan M, Thomas H, Thursz M, Tosti M, Trépo C, Vince A, Vounou E, Wiessing L, Manns M.

J Viral Hepat. 2013 Aug;20 Suppl 2:1-20. doi: 10.1111/jvh.12120. Erratum in: J Viral Hepat. 2013 Oct;20(10):744. Hadjichristodoulou, T [corrected to Hadjichristodoulou, C].

PMID:
23827008
20.

Osseointegration of biochemically modified implants in an osteoporosis rodent model.

Stadlinger B, Korn P, Tödtmann N, Eckelt U, Range U, Bürki A, Ferguson SJ, Kramer I, Kautz A, Schnabelrauch M, Kneissel M, Schlottig F.

Eur Cell Mater. 2013 Jul 8;25:326-40; discussion 339-40.

21.

Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement.

Schaefer M, Capuron L, Friebe A, Diez-Quevedo C, Robaeys G, Neri S, Foster GR, Kautz A, Forton D, Pariante CM.

J Hepatol. 2012 Dec;57(6):1379-90. doi: 10.1016/j.jhep.2012.07.037. Epub 2012 Aug 7.

PMID:
22878466
22.

The role of CNI-1493 in the function of primary microglia with respect to amyloid-β.

Bach JP, Mengel D, Wahle T, Kautz A, Balzer-Geldsetzer M, Al-Abed Y, Dodel R, Bacher M.

J Alzheimers Dis. 2011;26(1):69-80. doi: 10.3233/JAD-2011-110179.

PMID:
21593565
23.

[Waiting time for and length of physicianc's consultation define the patient-physician interaction: results of a prospective study in 478 patients with chronic viral hepatitis].

Niederau C, Bemba G, Kautz A, Bertram T, Schweizer R, van Thiel I.

Z Gastroenterol. 2010 Apr;48(4):455-64. doi: 10.1055/s-0028-1109762. Epub 2010 Mar 29. German.

PMID:
20352592
24.

Restoration of contact inhibition in human glioblastoma cell lines after MIF knockdown.

Schrader J, Deuster O, Rinn B, Schulz M, Kautz A, Dodel R, Meyer B, Al-Abed Y, Balakrishnan K, Reese JP, Bacher M.

BMC Cancer. 2009 Dec 28;9:464. doi: 10.1186/1471-2407-9-464.

25.

Biomechanical comparison of different surface modifications for dental implants.

Ferguson SJ, Langhoff JD, Voelter K, von Rechenberg B, Scharnweber D, Bierbaum S, Schnabelrauch M, Kautz AR, Frauchiger VM, Mueller TL, van Lenthe GH, Schlottig F.

Int J Oral Maxillofac Implants. 2008 Nov-Dec;23(6):1037-46.

PMID:
19216272
26.

Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation.

Burgdorf S, Schölz C, Kautz A, Tampé R, Kurts C.

Nat Immunol. 2008 May;9(5):558-66. doi: 10.1038/ni.1601. Epub 2008 Mar 30.

PMID:
18376402
27.

[Changes in socio-economics, quality of life and knowledge of patients with chronic hepatitis C during the Hepatitis Competence Net Project].

Niederau C, Bemba G, Kautz A.

Z Gastroenterol. 2008 Jan;46(1):22-33. doi: 10.1055/s-2007-963534. German.

PMID:
18188813
28.
29.

Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation.

Burgdorf S, Kautz A, Böhnert V, Knolle PA, Kurts C.

Science. 2007 Apr 27;316(5824):612-6.

32.

Different regions of primase subunit p48 control mouse polyomavirus and simian virus 40 DNA replication in vitro.

Kautz AR, Schneider A, Weisshart K, Geiger C, Nasheuer HP.

J Virol. 2001 Feb;75(4):1751-60.

33.

Primase activity of human DNA polymerase alpha-primase. Divalent cations stabilize the enzyme activity of the p48 subunit.

Schneider A, Smith RW, Kautz AR, Weisshart K, Grosse F, Nasheuer HP.

J Biol Chem. 1998 Aug 21;273(34):21608-15.

34.

A cell-free replication system for human polyomavirus JC DNA.

Nesper J, Smith RW, Kautz AR, Sock E, Wegner M, Grummt F, Nasheuer HP.

J Virol. 1997 Oct;71(10):7421-8.

Supplemental Content

Support Center